Frank Litvack
CIK 1310715 · CEO and Chairman · last filed 2026-05-14
Frank Litvack is a CEO and Chairman who has filed 24 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing shows the insider exercised options covering $5.5K of CAPR on May 14, 2026. Current disclosed insider exposure totals $4.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$4.65M
4
24
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CAPR | Director | 180,054 | $25.80 | $4.65M | $0 | 18 | 2026-05-14 |
| CAPRICOR THERAPEUTICS, INC. (NLTXW) Delisted | Director | 200,000 | — | — | $0 | 2 | 2011-05-12 |
| CAPRICOR THERAPEUTICS, INC. (NLTX) Delisted | Director | 200,000 | $13.96 | $2.79M | $0 | 1 | 2009-09-28 |
| CONOR MEDSYSTEMS INC (CONR) Delisted | CEO and Chairman | 0 | — | — | $0 | 2 | 2007-02-02 |
Recent Filings
24 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-14 | CAPR | Exer (M) | +3,937 | $5.5K | EDGAR |
| 2026-01-07 | CAPR | Grant (A) | — | $0 | EDGAR |
| 2025-03-04 | CAPR | Mixed | +22,457 | -$13 | EDGAR |
| 2025-01-06 | CAPR | Grant (A) | — | $0 | EDGAR |
| 2024-12-04 | CAPR | Mixed | +20,391 | $22.4K | EDGAR |
| 2024-01-04 | CAPR | Grant (A) | — | $0 | EDGAR |
| 2023-08-16 | CAPR | Mixed | +16,384 | -$6 | EDGAR |
| 2023-02-23 | CAPR | Mixed | +9,503 | -$1 | EDGAR |
| 2023-01-05 | CAPR | Grant (A) | — | $0 | EDGAR |
| 2022-01-04 | CAPR | Mixed | +86,991 | -$1 | EDGAR |